Expert Pitch

UAlbany Experts Available to Discuss COVID-19 Vaccine Rollout

University at Albany, State University of New York

ALBANY, N.Y. (Nov. 19, 2020) – The United States has now surpassed 11 million COVID-19 cases since February and many Americans are scrambling to figure out how to safely celebrate the upcoming holiday season. But, promising vaccine news could signal a start to the end of this historic pandemic.

Pfizer and BioNTech announced yesterday that a final analysis of their latest vaccine clinical trial results showed it was 95 percent effective against the virus. Moderna shared their own results on Monday, indicating a 94.5 percent effective rate.

University at Albany experts are available to discuss the challenges ahead and what can be done to increase public trust once a vaccine is approved.

Eli Rosenberg, School of Public Health

Rosenberg, an associate professor in the Department of Epidemiology and Biostatistics, has provided technical assistance to New York’s COVID-19 response across a range of activities and studies addressing critical aspects of SARS-CoV-2 transmission, surveillance, prevention and treatment.

He is also a member of Gov. Cuomo’s New York State COVID-19 Vaccine Distribution and Implementation Task Force and has offered expertise on COVID-19 epidemiology to the Governor’s office, the SUNY system, UAlbany and during numerous local and national media appearances.

“Having a highly efficacious COVID-19 vaccine is an important step towards controlling the spread of SARS-CoV-2. In order to fully realize the protective value of such a vaccine, we need to ensure its widespread distribution, access, and uptake. This will pose substantial challenges in the months ahead, particularly as we endeavor to ensure health equity. With the right investments, coordination, and community engagement, we can do this, but we must be honest about the scale of the public health challenge ahead.”

Rosenberg has extensive experience in conducting studies that address current public health challenges in HIV, STI, viral hepatitis, and emerging infectious diseases, with a focus on surveillance, prevention and social determinants.

Samantha Penta, College of Emergency Preparedness, Homeland Security and Cybersecurity (CEHC)

Penta is an assistant professor at CEHC and emergency management expert with a focus on health and medical issues during a crisis, decision-making in preparedness and response and humanitarian logistics. She has worked on numerous projects examining disaster donations behavior, planning and implementing international crisis medical relief, risk perception and protective actions.

During the COVID-19 crisis, Penta has lead a study funded through a National Science Foundation Rapid Response Research (RAPID) grant to examine risk perception, information seeking and protective actions against COVID-19 in New York, Louisiana and Washington. Her analysis is running at monthly intervals in order to capture changing behavior responses as the pandemic evolves.

"Achieving widespread vaccination is more than a medical research and production problem. It is also an issue of logistics and human behavior.”

“From a logistics perspective, it will entail everything from ensuring sufficient production of other components like syringes, to acquiring appropriate transportation and storage resources, identifying appropriate vaccination locations, and navigating a potential greater demand for PPE and testing capabilities. Once the infrastructure is established, it is ultimately the human dimension – things like perceptions of vaccine safety and effectiveness, and financial and time constraints – that will shape vaccination prevalence in our communities."

About the University at Albany:

A comprehensive public research university, the University at Albany-SUNY offers more than 120 undergraduate majors and minors and 125 master's, doctoral and graduate certificate programs. UAlbany is a leader among all New York State colleges and universities in such diverse fields as atmospheric and environmental sciences, businesseducation, public health, health sciences, criminal justice, emergency preparedness, engineering and applied sciences, informatics, public administration, social welfare and sociology, taught by an extensive roster of faculty experts. It also offers expanded academic and research opportunities for students through an affiliation with Albany Law School. With a curriculum enhanced by 600 study-abroad opportunities, UAlbany launches great careers.




Filters close

Showing results

110 of 4147
Newswise: COVID-19 Peer Hub combats vaccine avoidance amid pandemic
Released: 27-Nov-2020 8:05 AM EST
COVID-19 Peer Hub combats vaccine avoidance amid pandemic
University of South Australia

UniSA researchers are evaluating a new vaccination education initiative – the COVID-19 Peer Hub – to help immunisation and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction


Showing results

110 of 4147

close
1.14102